Peter C. Hollenhorst

发表

The GNUMAP algorithm: unbiased probabilistic mapping of oligonucleotides from next-generation sequencing

Mark J. Clement, Quinn Snell, Barbara J. Graves, 2010, Bioinform..

DNA Specificity Determinants Associate with Distinct Transcription Factor Functions

Barbara J. Graves, Peter C. Hollenhorst, N. Speck, 2009, PLoS genetics.

At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone

Peter C. Hollenhorst, John Foley, J. Foley, 2012, Odontology.

Extracellular Signal-Regulated Kinase Signaling Regulates the Opposing Roles of JUN Family Transcription Factors at ETS/AP-1 Sites and in Cell Migration

Peter C. Hollenhorst, P. Hollenhorst, M. Ferris, 2014, Molecular and Cellular Biology.

RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites

Peter C. Hollenhorst, P. Hollenhorst, 2012, Small GTPases.

Androgen signaling connects short isoform production to breakpoint formation at Ewing sarcoma breakpoint region 1

Peter C. Hollenhorst, P. Hollenhorst, T. R. Nicholas, 2020, bioRxiv.

Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family.

Peter C. Hollenhorst, Atul A Shah, B. Graves, 2007, Genes & development.

Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors.

Peter C. Hollenhorst, David A Jones, B. Graves, 2004, Nucleic acids research.

Microsatellites as EWS/FLI response elements in Ewing's sarcoma

Stephen C. Haroldsen, Peter C. Hollenhorst, L. Jorde, 2008, Proceedings of the National Academy of Sciences.

Genomic and biochemical insights into the specificity of ETS transcription factors.

Peter C. Hollenhorst, L. McIntosh, B. Graves, 2011, Annual review of biochemistry.

Common ELF1 deletion in prostate cancer bolsters oncogenic ETS function, inhibits senescence and promotes docetaxel resistance

Peter C. Hollenhorst, P. Hollenhorst, M. Ferris, 2018, Genes & cancer.

An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.

Peter C. Hollenhorst, P. Hollenhorst, T. Jerde, 2016, Cell reports.

Human RNA Polymerase III transcriptomes and relationships to Pol II promoters, enhancer-binding factors and chromatin domains

Peter C. Hollenhorst, Andrew J. Oler, B. Cairns, 2010, Nature Structural &Molecular Biology.

Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells

Peter C. Hollenhorst, P. Hollenhorst, Nagarathinam Selvaraj, 2015, Cell Communication and Signaling.

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma

Peter C. Hollenhorst, W. Linehan, G. Yousef, 2018, Clinical Cancer Research.

Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells

Peter C. Hollenhorst, P. Hollenhorst, T. Jerde, 2021, PLoS genetics.

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming.

Peter C. Hollenhorst, M. Seshadri, W. Tao, 2017, Cancer research.

Oncogenic ETS Factors in Prostate Cancer.

Peter C. Hollenhorst, P. Hollenhorst, T. R. Nicholas, 2019, Advances in experimental medicine and biology.

Mechanisms controlling differential promoter-occupancy by the yeast forkhead proteins Fkh1p and Fkh2p: implications for regulating the cell cycle and differentiation.

Peter C. Hollenhorst, P. Hollenhorst, C. Fox, 2001, Genes & development.

ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells

Peter C. Hollenhorst, P. Hollenhorst, M. Ferris, 2014, Nucleic acids research.

Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Peter C. Hollenhorst, B. Graves, P. Hollenhorst, 2011, Genes & development.

ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase.

Peter C. Hollenhorst, P. Hollenhorst, R. Emerson, 2018, Cancer letters.

Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2

Peter C. Hollenhorst, P. Hollenhorst, Joshua P. Plotnik, 2017, Nucleic acids research.

A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS

Peter C. Hollenhorst, P. Hollenhorst, T. R. Nicholas, 2020, PloS one.

Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation

Peter C. Hollenhorst, P. Hollenhorst, M. Ferris, 2014, Molecular Cancer.

The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells.

Peter C. Hollenhorst, B. Graves, P. Hollenhorst, 2010, Genes & cancer.

Expression Program in PC 3 Prostate Cells Is Required for Anchorage-Independent Growth and a Cell Proliferation Gene ETV 4 Gene ETS

Peter C. Hollenhorst, B. Graves, P. Hollenhorst, 2011 .

Forkhead genes in transcriptional silencing, cell morphology and the cell cycle. Overlapping and distinct functions for FKH1 and FKH2 in Saccharomyces cerevisiae.

Peter C. Hollenhorst, P. Hollenhorst, C. Fox, 2000, Genetics.

Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma

Peter C. Hollenhorst, N. Donato, M. Talpaz, 2017, Nature Communications.

Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target

Peter C. Hollenhorst, P. Hollenhorst, T. Jerde, 2021, NAR cancer.

The GNUMAP algorithm: unbiased probabilistic mapping of oligonucleotides from next-generation sequencing

Peter C. Hollenhorst, Q. Snell, M. Clement, 2010, Bioinform..

Emerging In Vivo Analyses of Cell Function Using Fluorescence Imaging ∗

Peter C. Hollenhorst, W. DeGrado, L. McIntosh, 2011 .

Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors.

Peter C. Hollenhorst, David A Jones, B. Graves, 2004, Nucleic acids research.

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming.

Peter C. Hollenhorst, M. Seshadri, W. Tao, 2017, Cancer research.